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EXPERIMENTAL AND CLINICAL STUDIES OF
        URINTARY BLADDER CANTCER
                           Tadashi HiRAMATsu
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   Biadder’ tumors induced by BBN in rats and dogs were useful for the clinical studies ．of hvmah
urinary bladder tumors and experi皿ental chemotherapy．5－FU， FT－207，（〕Q， VCR． and CDDP
were effective as single agents； and， the combination of FT－207 and OK－432， FT－207， ADM and
OK－432，’@and， VCR， BLM and ADM were effective in significantly inhibiting the development
of bladder tumers induced by BBN in Wistar rats． ln clinical cases， the・ administration of FT－207，
biadder instillation of an anticancer drug， and pre－operative intra－arteriaユi漁sion of MMC in ad－
dition to bladder instillation were prophylactic for the recurrence of the superficial urinary bladder
cancers significantly within one year after operation． ADiM， CDDP and radiation were effective
regimens fbr advanced u血ary bladder cancers．”（ultidisciplinary treatment was use血1 in．．treating
advanced urinary bJadder cancers．
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Table 1． lnterrelationship between the observation
     period after the treatment with O．05 O／，
     BBN for 8 weeks and the incidence ol’
     urinary bladder tumors in Wistar strain
     malc ra亡S
Period（weeks＞     Effectivewith without
     No．of ratsBBN BBN
Changes in urinary bladder（efo）
Hyperpiasia PapMoma Cancer
8   0 6
8   4 6








2（ 33．3） O（ O．O）
3（ 50．0） O（ O．O）
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adriamycin （ADM）， mitomycin C （MMC），
cyclophosphamide （CPM）， 5－fluorouracil （5－Fu），
futrafu1 （FT－207）， neocarzinostatine （NaS），























投与終了後CQ O．5mg！kg ip 7日間のみ投与群，
第21群のv（〕Ro．1mg／kg ip投与群，第23群の




























o 8 20 Weeks
1 BBN
2  ADM  lmg／kg




7  CPM  50mg／kg
8 5Fu 20rng／kg
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： ：intraperitoneat administration
r［ir．inw：’Tffi ： OraS administration
ua ：O．05 9・to BBN in drinking water
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                                  S intraperitoneal administration
                                  ua ： O．5 90 BBN in drinkng water
Fig． 2． Experimenta1 design on chemotherapy of urinary bladder tumors induced by BBN in rats
Table 3．Results． of effec．tive chemotherapeutics by single administration on the development
of bladder tumors in ratS treated with O．e50／． BBN for 8 weeks
Expeゆentai
group
No．of Changes in urlnary bladder （％）
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Resuks of effective chemotherapeutics by single administration on the developrnent
of bladder tumors in rats treated with O．05％ BBN for 8 weeks
Experimental
group．
Nt o．of Ohanges in urinary bladder （O／o）
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                                    3・ ： intraperiteneal administration
                                    g ：cornEsined administration
                                       FTd－207十〇K－432 or十ADM
                                      ： VCR．BLM （day 1）， ADM （day 1，2．3）
                                      ：VCR→Bし1哺（day 1）r C＝）DP（d3y 1・2タ3・4「5）
                                     1．｛ptZl．．t・ff±is±s一一一．．．一・：O；’al adminicv－t’g’atlon
                                     賜：0．05％ BB彊 in 感聾耀nking wator
Fig． 3． Experimental design on chemotherapy of urinary bladder tumors induced by BBN in rats
Table 5．Results of cornbined immunochemotherapy on the
in rats treated with O．050／． BBN for 8 weeks
dev l pm nt of bladder tumors
Experimental No， of lncidence of changes in urinary bladder （O／o）


























































































 その結果についてみると，術前MMC one shot
動注を施行した症例については動注後7～14日後に膀
Table 6． Methods of prophylactic treatment of
     superficial bladder tumors treated with
     conservatlve surgery
Methods M， F， Total
Without prophylactic treatment
With pre－operative treatment
 MMC one shot into A． j］iaca jnt．
WiSh Rc st．一〇perative treatment
 lnstillation
 MMC 30一一60mg






























































   No．ofStage   cases・・C…g・§ぎ懸
Ti 42
丁2  18
26（61．9） 8（19．0） 2（4．8） 2（ 4．8） 4（ 9．5）
11（61．1） 5（27．8） 2（11．1）．








 All cases n＝58
 Cases with multiple tumors n＝19
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Fig．4．5－year recurrent rate in cases without prophylactic treatment
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    A］l cases n＝1ア3
“＋．一．一一 ： Cases with multiple tumors n＝66
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        ： Cases without treatment n＝39
        ： Cases with FT－207 n＝15
一一一： Cases wi’th instillation alone n＝55
  一・一 ： Cases with MMC（A）＋instillation n＝35
MMC（A）：pre－operative injection’ into A．Iliaca
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       ： Cases without treatment n＝19
一一一一一一： Cases with FT－207 n＝14
一一一： Cases with instjllation alone n＝32
一’一一一： Cases with MMC（A）＋instillation n＝17
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MMC（・A）：pre－operative injection into A．11iaca
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Cases without prophylactic tveatment n＝9
All cases with prophylactic treatment n＝31
Cases with bladder instVlation alone n＝21
6 Mos．1 2 3 4 ．5 Yea．rs
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Table 9． Clinical response of the chemotherapy
     without radiation in cases with invasive
     bladder cancers according to criteria of































17 6 7  2  2
PD ： Progressive disease
NC： No change
PR ： Partial’ response
CR ： Complete response
Table 8．Clinical response of radiation with or without chemotherapy in cases with invasive
bladder cancers according to criteria of Koyama－Saito Group










































Tota1 35 18 6 8  3
PD ： Progressive disease
NC ： No change
PR ： Partial response
CR ： Complete response
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Fig． 10． CT scan before pre－operative
    chemotherapy Fig． 11． CT scan after pre－operative    chemotherapy
Table 10． lncidence of metastasis after curable surgery with post－operative adjuvant therapy


































































1． Superficial bladder cancers
  a） pre－operati・ve Ml C（A） ＋ TUR ＋ instillation and FT－207
  b）． TUR ＋ instVlation and FT－207
2． lnvasive bladder cancers
凹ulti－disciplinary treatment
Pl至聖1畔 ＿＿蜘晶ざ男1黙ω
          う撚1附CDD，。． A，， w’th lymphadenectomゾ羅1譜、（一）
A9麟…鷺晦CDDP㏄AD糖罫i籍：iぎ
誌瓢・一・・羅M“CDDP o「 ADM欝iゼ騰t
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